You are here: Welcome to the MPKB » Welcome to the MPKB » Publications & presentations » Applications to the FDA for orphan drug status for Marshall Protocol medications
Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Last revisionBoth sides next revision
home:publications:applications_orphan_status [03.06.2011] – external edit 127.0.0.1home:publications:applications_orphan_status [04.24.2011] – paulalbert
Line 1: Line 1:
- ====== Applications to the FDA for orphan drug status for Marshall Protocol medications ======+~~NOTOC~~ 
 + 
 +====== Applications to the FDA for orphan drug status for Marshall Protocol medications ======
  
 Autoimmunity Research Foundation has submitted multiple applications to the Office of Orphan Products Development, a division of the FDA. The goal of submitting these applications would be to make it easier for doctors to prescribe and harder for insurance companies to deny coverage of MP medications. Autoimmunity Research Foundation has submitted multiple applications to the Office of Orphan Products Development, a division of the FDA. The goal of submitting these applications would be to make it easier for doctors to prescribe and harder for insurance companies to deny coverage of MP medications.
home/publications/applications_orphan_status.txt · Last modified: 07.04.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.